QCMA
PFE icon

Quad Capital Management Advisors’s Pfizer PFE Stock Holding History

Quad Capital Management Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,175
Closed -$446K – 123
2017
Q3 		$446K Buy
+13,175
New +$423K 0.09% 62

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quad Capital Management Advisors's PFE Position: Q4 2017 in Review

Quad Capital Management Advisors sold out of Pfizer (PFE) in Q4 2017, closing a stake of 13,175 shares — an estimated $446K sold.

Quad Capital Management Advisors first reported a position in PFE in Q3 2017 and held it in 1 quarter. The position peaked at $446K in Q3 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Quad Capital Management Advisors reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Quad Capital Management Advisors sold 13,175 Pfizer shares in Q4 2017, an estimated $446K.
  • Quad Capital Management Advisors first reported a position in Pfizer in Q3 2017 and held it in 1 quarter.
  • Quad Capital Management Advisors's Pfizer position peaked at $446K in Q3 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Quad Capital Management Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.